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Case Presentation: Spontaneous mesenteric haematoma is a rare condition that occurs due to localized bleeding in
the mesenteric vascular tree of a bowel segment in the absence of an identifiable cause. Here we report a case of
spontaneous mesenteric haematoma during an inflammatory exacerbation of Crohn’s disease. The patient underwent
surgical management for small bowel obstruction secondary to Crohn’s disease, however the concurrent presence of a
spontaneous mesenteric haematoma in the mid-jejunal mesentery was successfully managed conservatively.
Conclusion: This case identifies the first association of spontaneous mesenteric haematoma with an exacerbation of
Crohn’s disease and highlights the need to consider rare differential diagnoses such as SMH when performing
radiological assessment of unexplained symptoms in inflammatory bowel disease patients.
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Spontaneous mesenteric haematoma (SMH) is a rare
condition of unknown aetiology. It can be managed con-
servatively in the event that there is no associated mes-
enteric haemorrhage. It must be clinically distinguished
from spontaneous mesenteric intraperitoneal haemor-
rhage (or abdominal apoplexy) where there is rupture
or bleeding from a specific mesenteric vessel due to an
unknown cause that typically requires urgent surgical man-
agement due to its high mortality. This report presents the
first case in the literature associating SMH with an inflam-
matory exacerbation of Crohn’s disease.Case presentation
A 44-year-old female presented with an exacerbation of
Crohn’s disease that was not responsive to medical manage-
ment with escalating steroid (prednisolone) and purine
analogue (azathioprine) therapy. She was a non-smoker and
aside from well-controlled essential hypertension had no
other significant co-morbidities. Her inflammatory bowel
disease had already required two previous hospitalizations,
and she had suffered from symptoms of intermittent pain* Correspondence: h.ashrafian@imperial.ac.uk
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reproduction in any medium, provided the orand bloating with constipation throughout the 12 months
since her diagnosis. In the preceding month a computed
tomography (CT) scan revealed 3 segments of Crohn’s
disease strictures with prestenotic dilatation and an inflam-
matory appearance (Figure 1a). No mesenteric haematoma
was identified at this point (Figure 1b). Blood tests taken at
this time were unremarkable with a haemaglobin (Hb) of
11.7 g/dl, white cell count (WCC) of 5.4 × 109/L and a
C-reactive protein (CRP) of 7 mg/L. Her symptoms initially
resolved with intravenous hydrocortisone but promptly re-
curred with worsening malnutrition despite intensifying
steroid therapy. She had not received any formal anticoagu-
lation other than prophylactic subcutaneous low-molecular
weight heparin (20 mg once daily) during the period of her
hospitalization. Repeat CT scan (Figure 2) demonstrated a
significant deterioration in small bowel dilatation with
impending obstruction due to a 10 cm distal ileal stricture
and a left upper quadrant abdominal ‘mass’ (9 × 12 × 20
cm), thought to be an inflammatory phlegmon secondary to
an area of more proximal Crohn’s disease. Repeat blood
tests at this time revealed anaemia with a haemaglobin
of 8.6 g/dl, a normal WCC of 6.5 × 109/L and a CRP of
25 mg/L. No clotting abnormalities were identified and
liver function tests were unremarkable.
Subsequent laparotomy identified a grossly dilated
segment of ileum proximal to a terminal ileal stricture.
There was also a large haematoma within the mesenteryal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Initial computed tomography (CT) scan demonstrating (a) Crohn’s strictures; (b) Absence of mesenteric haematoma.
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onstrated on CT (Figure 3). There was no evidence of
local vascular trauma or pancreatico-biliary inflammation.
The loop of jejenum was viable and macroscopically nor-
mal without any associated signs of Crohn’s disease. The re-
mainder of the small and large bowel also appeared
normal. The patient underwent a limited right hemicolect-
omy and double barrel stoma formation from the ileum
and ascending colon. After surgery she was placed on an
enhanced recovery protocol and was discharged on the 5th
post-operative day. She is currently well and to date her
follow-up has remained un-eventful.
Discussion
The surgical complications of Crohn’s disease include
bowel obstruction, fistulation, ulceration, anal fissures
and cancer [1]. The pathological severity of this condi-
tion derives from a combination of inherited factors andenvironmental triggers that lead to gut inflammation
and local microvascular ischaemia [2,3]. The vascular
component of Crohn’s disease has been primarily associ-
ated with arterial and venous thrombotic events that can
lead to mesenteric ischaemia, venous congestion and
bowel perforation [1,4]. There is an association between
patients with Crohn’s disease who suffer from intramural
bowel haematomas, bleeding diatheses and anticoagulation
therapy [5]. To the best of our knowledge, we report the
first case in the literature of spontaneous jejunal mesenteric
(mesojejunal) haematoma.
Spontaneous mesenteric haematoma (SMH) is a rare
condition that occurs due to localized bleeding in the
mesenteric vascular tree of a bowel segment with un-
known aetiology [6-8]. It can be clinically distinguished
from the related disease pathology of spontaneous mesen-
teric intraperitoneal haemorrhage (abdominal apoplexy)
that occurs due to the spontaneous rupture of a specific
Figure 2 Computed tomography (CT) scan demonstrating small bowel obstruction and mesenteric haematoma taken at the same
anatomical level as Figure 1b.
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terial dissection and perivascular pseudo aneurysms. In
these cases there is evidence of both intraperitoneal and
retroperitoneal haemorrhage [9]. SMH can be managed
conservatively [6-8] if there is no associated haemorrhage
and although the patient in this case underwent surgery
for intestinal stenosis, the concurrent mesenteric haema-
toma was successfully managed conservatively.
Patients with isolated SMH typically present with non-
specific symptoms of generalised abdominal pain and as
a result the haematoma is usually identified on imaging
modalities such as CT. Although the cause is unknown,
the disease process may be associated with unidentifiedFigure 3 Intraoperative image of mid-jejunal mesenteric haematoma.anticoagulation mismanagement or even undiagnosed
connective tissue disease [6-8].
Our case demonstrates the presence of localised mid-
jejunal mesenteric fat haematoma. Localised visceral
inflammation is a recognised contributor to confined
microvascular bleeding [10] so that the inflammatory
exacerbation of Crohn’s disease in this case may have re-
sulted in severe mesenteric fat inflammation to initiate
localised capillary leakage and subsequent haematoma.
Mesenteric fat has been recently recognised an essen-
tial location for the generation of Crohn’s gastrointes-
tinal inflammation [11,12]. Here bacterial translocation
associated with immunoregulation through nucleotide-
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Toll-like receptors (TLRs 2 and 4) result in an increase
in local inflammatory mediators including C-reactive-
protein (CRP). The powerful inflammatory role of the
bowel mesentery might be a contributory factor in the
association between Crohn’s exacerbation and mesen-
teric haematoma in this case.
Our intraoperative findings of mesojejunal haematoma
reflect the current underestimation of Crohn’s ileitis,
demonstrating explicit involvement of the mesenteric fat
with an associated mesenteric haematoma. This case
also highlights how mesenteric abnormalities such as
SMH may explain refractoriness or recurrence of symp-
toms despite intensifying steroid therapy. Indeed, it is
possible that ileal compression caused by a mesenteric
mass such as this may explain many of the symptoms
accredited to Crohn’s strictures. As a result, we believe
that an increased awareness of the role of the bowel
mesentery may give new insights into Crohn’s disease
pathogenesis. Furthermore, assessment for mesenteric
abnormalities may guide future clinical and radiological
assessment of unexplained symptoms in patients suffer-
ing form this multi-systemic inflammatory process, and
identify rare differential diagnoses such as SMH.
Conclusion
We describe a case of spontaneous mesenteric haema-
toma in a female patient suffering from an exacerbation
of Crohn’s disease and intestinal stenosis. The mesen-
teric haematoma was identifiable both on pre-operative
computerised tomography and intra-operatively. This
case identifies the first association of spontaneous mes-
enteric haematoma with an exacerbation of Crohn’s dis-
ease and highlights the need to consider rare differential
diagnoses such as SMH when performing radiological
assessment of unexplained symptoms in inflammatory
bowel disease patients.
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